PDSB PDS Biotechnology Corporation

7.04
+0.39  (+6%)
Previous Close 6.65
Open 6.61
Price To Book 1.49
Market Cap 36449508
Shares 5,177,487
Volume 76,832
Short Ratio
Av. Daily Volume 183,596

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 trial planned for 4Q 2019.
PDS0101
Human papilloma virus (HPV)
Phase 2 planned for 4Q 2019.
PDS0101 and Keytruda
Head and neck cancer